Lifecore Biomedical (LFCR) Competitors $7.48 +0.39 (+5.50%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LFCR vs. AVD, OMN, SENEA, ODC, AVDL, ZYME, SEPN, COGT, BCAX, and BCYCShould you be buying Lifecore Biomedical stock or one of its competitors? The main competitors of Lifecore Biomedical include American Vanguard (AVD), OMNOVA Solutions (OMN), Seneca Foods (SENEA), Oil-Dri Co. of America (ODC), Avadel Pharmaceuticals (AVDL), Zymeworks (ZYME), Septerna (SEPN), Cogent Biosciences (COGT), Bicara Therapeutics (BCAX), and Bicycle Therapeutics (BCYC). Lifecore Biomedical vs. American Vanguard OMNOVA Solutions Seneca Foods Oil-Dri Co. of America Avadel Pharmaceuticals Zymeworks Septerna Cogent Biosciences Bicara Therapeutics Bicycle Therapeutics Lifecore Biomedical (NASDAQ:LFCR) and American Vanguard (NYSE:AVD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, community ranking, analyst recommendations and profitability. Does the MarketBeat Community prefer LFCR or AVD? American Vanguard received 290 more outperform votes than Lifecore Biomedical when rated by MarketBeat users. Likewise, 60.96% of users gave American Vanguard an outperform vote while only 20.00% of users gave Lifecore Biomedical an outperform vote. CompanyUnderperformOutperformLifecore BiomedicalOutperform Votes220.00% Underperform Votes880.00% American VanguardOutperform Votes29260.96% Underperform Votes18739.04% Do analysts prefer LFCR or AVD? Lifecore Biomedical presently has a consensus price target of $8.00, suggesting a potential upside of 6.95%. American Vanguard has a consensus price target of $16.67, suggesting a potential upside of 169.25%. Given American Vanguard's stronger consensus rating and higher possible upside, analysts clearly believe American Vanguard is more favorable than Lifecore Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifecore Biomedical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50American Vanguard 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, LFCR or AVD? Lifecore Biomedical has higher earnings, but lower revenue than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Lifecore Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifecore Biomedical$128.44M2.14$12.01M$0.0893.50American Vanguard$579.37M0.31$7.52M-$1.03-6.01 Which has more volatility & risk, LFCR or AVD? Lifecore Biomedical has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Comparatively, American Vanguard has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500. Does the media refer more to LFCR or AVD? In the previous week, American Vanguard had 5 more articles in the media than Lifecore Biomedical. MarketBeat recorded 5 mentions for American Vanguard and 0 mentions for Lifecore Biomedical. American Vanguard's average media sentiment score of 1.09 beat Lifecore Biomedical's score of 0.36 indicating that American Vanguard is being referred to more favorably in the news media. Company Overall Sentiment Lifecore Biomedical Neutral American Vanguard Positive Is LFCR or AVD more profitable? Lifecore Biomedical has a net margin of 5.09% compared to American Vanguard's net margin of -5.22%. American Vanguard's return on equity of -3.45% beat Lifecore Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Lifecore Biomedical5.09% -382.65% -10.21% American Vanguard -5.22%-3.45%-1.57% Do institutionals & insiders have more ownership in LFCR or AVD? 83.4% of Lifecore Biomedical shares are owned by institutional investors. Comparatively, 79.0% of American Vanguard shares are owned by institutional investors. 28.2% of Lifecore Biomedical shares are owned by company insiders. Comparatively, 10.1% of American Vanguard shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryAmerican Vanguard beats Lifecore Biomedical on 10 of the 18 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFCR vs. The Competition Export to ExcelMetricLifecore BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$275.47M$6.44B$5.05B$8.82BDividend YieldN/A8.11%5.17%4.07%P/E Ratio93.5010.69125.6917.78Price / Sales2.14243.731,179.7874.25Price / CashN/A22.1633.7732.53Price / Book20.225.474.684.68Net Income$12.01M$153.61M$119.54M$226.08M7 Day Performance5.50%-4.32%-2.46%-2.04%1 Month Performance43.57%-8.61%-4.08%0.06%1 Year Performance0.67%28.79%29.82%24.60% Lifecore Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFCRLifecore Biomedical1.5431 of 5 stars$7.48+5.5%$8.00+7.0%+0.7%$261.10M$128.26M93.50690AVDAmerican Vanguard4.078 of 5 stars$6.19-2.5%$16.67+169.3%-32.9%$182.80M$553.84M-6.01845Positive NewsOMNOMNOVA SolutionsN/A$10.14flatN/AN/A$454.82M$736.20M30.731,850SENEASeneca Foods1.0784 of 5 stars$69.96+0.0%N/A+45.1%$481.88M$1.46B12.002,900ODCOil-Dri Co. of America2.6277 of 5 stars$68.82+0.1%N/A+19.3%$501.33M$437.59M12.65870News CoverageAVDLAvadel Pharmaceuticals2.3424 of 5 stars$10.75+0.3%$24.43+127.2%-7.5%$1.03B$138.16M-13.61154Short Interest ↓ZYMEZymeworks2.8655 of 5 stars$14.55-1.5%$19.00+30.6%+74.0%$1.02B$76.01M0.00290SEPNSepternaN/A$22.50-7.0%$43.67+94.1%N/A$1.02BN/A0.00N/AAnalyst ForecastNews CoverageGap UpCOGTCogent Biosciences2.866 of 5 stars$9.08+0.2%$14.83+63.4%+20.6%$1.00BN/A0.0080Analyst RevisionBCAXBicara Therapeutics3.1692 of 5 stars$18.38-4.9%$43.33+135.8%N/A$1.00BN/A0.0032Analyst RevisionBCYCBicycle Therapeutics2.8495 of 5 stars$20.36-0.6%$40.13+97.1%+49.4%$968.12M$26.98M-6.19240Analyst Revision Related Companies and Tools Related Companies American Vanguard Competitors OMNOVA Solutions Competitors Seneca Foods Competitors Oil-Dri Co. of America Competitors Avadel Pharmaceuticals Competitors Zymeworks Competitors Septerna Competitors Cogent Biosciences Competitors Bicara Therapeutics Competitors Bicycle Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LFCR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFCR Stock Alerts